UBS Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,429
| Closed | -$150K | – | 9443 |
|
|
2021
Q2 | $150K | Sell |
4,429
-40,268
| -90% | -$1.36M | ﹤0.01% | 4547 |
|
|
2021
Q1 | $1.05M | Buy |
44,697
+43,374
| +3,278% | +$1.01M | ﹤0.01% | 3316 |
|
|
2020
Q4 | $38K | Buy |
+1,323
| New | +$38K | ﹤0.01% | 5439 |
|
|
2020
Q3 | – | Sell |
-8
| Closed | – | – | 7625 |
|
|
2020
Q2 | $0 | Sell |
8
-2,641
| -100% | – | ﹤0.01% | 7489 |
|
|
2020
Q1 | $83K | Sell |
2,649
-11,256
| -81% | -$353K | ﹤0.01% | 4580 |
|
|
2019
Q4 | $655K | Buy |
13,905
+1,912
| +16% | +$90.1K | ﹤0.01% | 3677 |
|
|
2019
Q3 | $77K | Buy |
11,993
+9,201
| +330% | +$59.1K | ﹤0.01% | 4997 |
|
|
2019
Q2 | $34K | Buy |
+2,792
| New | +$34K | ﹤0.01% | 5376 |
|
|
2019
Q1 | – | Sell |
-1,985
| Closed | -$8K | – | 7281 |
|
|
2018
Q4 | $8K | Buy |
1,985
+713
| +56% | +$2.87K | ﹤0.01% | 6449 |
|
|
2018
Q3 | $9K | Buy |
+1,272
| New | +$9K | ﹤0.01% | 6310 |
|